DOI QR코드

DOI QR Code

Clinical Implication of Tumor Markers

종양 표지자의 임상적 유용성

  • Oh, Sang-Cheul (Division of Hemato-oncology, Department of Internal Medicine, Korea University College of Medicine)
  • 오상철 (고려대학교 의과대학 종양혈액내과)
  • Published : 2012.08.01

Abstract

Keywords

References

  1. Locker GY, Hamilton S, Harris J, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006;24:5313-5327. https://doi.org/10.1200/JCO.2006.08.2644
  2. Desch CE, Benson AB 3rd, Somerfield MR, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2005; 23:8512-8519. https://doi.org/10.1200/JCO.2005.04.0063
  3. Chou R, Croswell JM, Dana T, et al. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2011;155:762-771. https://doi.org/10.7326/0003-4819-155-11-201112060-00375
  4. Ministry of Health and Welfare. Notice of Insurance reimbursement of Tumor Marker (Notice 2007-92). 2007.

Cited by

  1. Analyses of Risk Factors of Age-related Macular Degeneration Using Routine Health Check-up Data vol.62, pp.1, 2021, https://doi.org/10.3341/jkos.2021.62.1.46